MRNA Moderna, Inc. Stock Quote

MRNA [NASD]

Index	S&P 500	P/E	4.11	EPS (ttm)	32.80	Insider Own	5.40%	Shs Outstand	396.00M	Perf Week	-0.76%
Market Cap	52.92B	Forward P/E	16.59	EPS next Y	8.13	Insider Trans	-9.77%	Shs Float	353.82M	Perf Month	-26.26%
Income	14.05B	PEG	-	EPS next Q	4.81	Inst Own	64.10%	Short Float	4.23%	Perf Quarter	-7.18%
Sales	23.00B	P/S	2.30	EPS this Y	-1.80%	Inst Trans	-1.64%	Short Ratio	3.01	Perf Half Y	4.35%
Book/sh	45.42	P/B	2.97	EPS next Y	-69.54%	ROA	56.60%	Target Price	221.40	Perf Year	-69.09%
Cash/sh	20.13	P/C	6.70	EPS next 5Y	-	ROE	94.80%	52W Range	115.61 - 464.85	Perf YTD	-46.89%
Dividend	-	P/FCF	5.74	EPS past 5Y	111.10%	ROI	81.90%	52W High	-69.87%	Beta	1.69
Dividend %	-	Quick Ratio	1.70	Sales past 5Y	179.40%	Gross Margin	82.30%	52W Low	21.16%	ATR	7.81
Employees	2700	Current Ratio	2.00	Sales Q/Q	9.10%	Oper. Margin	68.00%	RSI (14)	43.34	Volatility	5.28% 4.94%
Optionable	Yes	Debt/Eq	0.04	EPS Q/Q	-18.70%	Profit Margin	61.10%	Rel Volume	1.71	Prev Close	134.90
Shortable	Yes	LT Debt/Eq	0.04	Earnings	Aug 03 BMO	Payout	0.00%	Avg Volume	4.98M	Price	140.07
Recom	2.50	SMA20	-5.69%	SMA50	-11.78%	SMA200	-19.81%	Volume	1,729,459	Change	3.83%

Sep-08-22

Upgrade

Deutsche Bank

Hold → Buy

$165

Feb-01-22

Upgrade

Redburn

Sell → Neutral

Jan-26-22

Upgrade

Deutsche Bank

Sell → Hold

$175

Jan-21-22

Upgrade

BofA Securities

Underperform → Neutral

$135 → $180

Jan-21-22

Initiated

UBS

Neutral

$221

Dec-07-21

Initiated

Cowen

Market Perform

Nov-09-21

Initiated

Wolfe Research

Outperform

$304

Oct-22-21

Initiated

Deutsche Bank

Sell

$250

Oct-15-21

Upgrade

Piper Sandler

Neutral → Overweight

$445

Aug-06-21

Downgrade

Piper Sandler

Overweight → Neutral

$246 → $445

Aug-06-21

Downgrade

Oppenheimer

Outperform → Perform

Jul-15-21

Reiterated

Jefferies

Hold

$170 → $250

Feb-01-21

Downgrade

BofA Securities

Neutral → Underperform

Dec-16-20

Downgrade

Morgan Stanley

Overweight → Equal-Weight

$150

Dec-16-20

Downgrade

Jefferies

Buy → Hold

$90 → $150

Dec-09-20

Downgrade

Needham

Buy → Hold

Nov-23-20

Initiated

Wells Fargo

Equal Weight

$92

Nov-17-20

Downgrade

BMO Capital Markets

Outperform → Market Perform

$109

Sep-08-20

Downgrade

SVB Leerink

Mkt Perform → Underperform

$58 → $41

Jul-23-20

Initiated

SVB Leerink

Mkt Perform

Sep-08-22 10:15AM	2 Top Healthcare Stocks to Buy for September Motley Fool
07:44AM	Asana, GameStop, Moderna, Revance, and More Stock Market Movers Thursday Barrons.com
07:00AM	Moderna Reviews Clinical Trial Programs Across Portfolio at 2022 R&D Day ACCESSWIRE
Sep-07-22 08:00AM	Is Moderna Stock A Buy After FDA Signs Off On Its Updated Covid Shot? Investor's Business Daily
Sep-06-22 07:35PM	Covid Is Likely to Require Yearly Booster Like Flu Shot, Fauci Says Bloomberg -6.13%
04:49PM	Why Moderna Stock Slumped Today Motley Fool
04:05PM	Moderna to Present at the Morgan Stanley 20th Annual Global Healthcare Conference ACCESSWIRE
03:50PM	Fall Boosters Are Here. Your Questions, Answered. Barrons.com
02:07PM	U.S. Plans Shift to Annual Covid Shots as New Boosters Roll Out The Wall Street Journal
10:16AM	3 Robinhood Stocks to Buy Right Now Motley Fool
Sep-05-22 03:59PM	25 Biggest Pharmaceutical Companies in the World A Year Ago Insider Monkey
09:04AM	10 Dividend Stocks to Buy According to Bruce Kovners Caxton Associates LP Insider Monkey
Sep-02-22 04:11PM	Pfizer, Moderna Dip Despite CDC Green-Light For Updated Covid Shots Investor's Business Daily
11:31AM	Moderna (MRNA) Down 28.4% Since Last Earnings Report: Can It Rebound? Zacks
09:21AM	EXPLAINER-Updated COVID vaccines are coming to U.S. Should you get one? Reuters
09:06AM	PFE, BNTX and MRNA Omicron Boosters Get Positive CHMP Opinion Zacks
07:59AM	The Zacks Analyst Blog Highlights Pfizer /BioNTec and Moderna's Zacks
07:31AM	Taiwan approves Omicron-targeted Moderna COVID vaccine Reuters
Sep-01-22 07:54PM	Covid Boosters Targeting Omicron Recommended by CDC The Wall Street Journal +5.05%
07:33PM	CDC backs updated COVID-19 boosters to fight omicron; shots expected within days MarketWatch
06:16PM	CDC approves omicron-targeting boosters. People could begin receiving the shots next week. American City Business Journals
12:14PM	UPDATE 2-Canada authorizes its first Omicron-adapted vaccine for adults Reuters
11:10AM	Has it been two months since your last COVID-19 shot? You may soon qualify for a newly designed booster MarketWatch
11:00AM	Health Canada Authorizes Moderna's Omicron-Targeting Bivalent COVID-19 Booster Vaccine ACCESSWIRE
10:48AM	FDA Authorizes Pfizer, Moderna's Omicron-Based Boosters Zacks
10:41AM	Pharma Stock Roundup: FDA Authorization of Omicron Boosters, SNY's Xenpozyme & More Zacks
10:00AM	2 Big Red Flags and 1 Small Green Flag For Pfizer Stock Motley Fool
09:01AM	UPDATE 3-EU regulator backs two Omicron-adapted COVID boosters Reuters
09:00AM	EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of Moderna's Omicron-Targeting Bivalent Booster in the European Union ACCESSWIRE
08:44AM	Is the Options Market Predicting a Spike in Moderna (MRNA) Stock? Zacks
Aug-31-22 06:45PM	Why Novavax Stock Got Pummeled Today Motley Fool
05:04PM	Why Moderna Stock Slumped on Wednesday Motley Fool
04:06PM	Will Updated Covid Boosters Save Pfizer, Moderna? The Stocks Say No Investor's Business Daily
03:47PM	Pfizer, Moderna booster shots are set to receive FDA authorization Yahoo Finance Video
03:40PM	FDA Authorizes New Booster Shots Aimed at Omicron Subvariants WSJ
01:41PM	New Covid cases, deaths keep falling nearly everywhere, WHO says MarketWatch
01:22PM	Biotech Stock Roundup: BMY's Study Update, INCY's Drug Label Expansion, MRNA News Zacks
12:53PM	Covid-19 Booster Shots Targeting Omicron Authorized, Likely to Be Offered Soon The Wall Street Journal
12:25PM	US approves Omicron vaccines from Moderna and BioNTech/Pfizer Financial Times
12:17PM	New Covid-19 Booster Shots for This Fall: What to Know The Wall Street Journal
11:50AM	Moderna and Pfizer Omicron Booster Shots Cleared by FDA Barrons.com
10:25AM	Moderna Receives FDA Authorization for Emergency Use of Omicron-Targeting Bivalent COVID-19 Booster Vaccine for Adults 18 Years and Older ACCESSWIRE
10:17AM	FDA authorizes omicron-targeting booster vaccines American City Business Journals
10:10AM	U.S. clears updated COVID boosters targeting newest variants MarketWatch
09:57AM	UPDATE 4-U.S. FDA green lights Omicron-targeted COVID boosters ahead of revaccination campaign Reuters
07:07AM	UPDATE 1-Europe to receive Omicron vaccines within days of approval, says MEP Reuters
06:00AM	Could Pfizer Beat Moderna in This New Billion-Dollar Market? Motley Fool
05:52AM	Should Pfizer Investors Be Worried About Moderna's Lawsuits? Motley Fool
Aug-30-22 01:11PM	Moderna's (MRNA) Omicron Based Jab gets Approval in Australia Zacks
12:09PM	Fauci on COVID-19: 'Were not going to eradicate the virus' Yahoo Finance
09:33AM	Company News for Aug 30, 2022 Zacks
06:00AM	After Double-Digit Percentage Declines, Are Vaccine Stocks Buys? Motley Fool
01:00AM	Therapeutic Goods Administration Provisionally Approves Modernas Omicron-Containing Bivalent Booster Candidate, MRNA-1273.214, For Australia ACCESSWIRE
Aug-29-22 07:14PM	10 Best Biotech Stocks To Buy Now Insider Monkey
12:05PM	Pfizer (PFE), BioNTech Seek EU Nod for Omicron-Based Booster Zacks
11:37AM	Moderna (MRNA) Sues Pfizer and BioNTech Over COVID Jab Zacks
11:35AM	Switzerland Approves First Next-Generation Bivalent COVID-19 Booster Vaccine Benzinga
10:30AM	Omicron-targeting COVID boosters expected this week, but experts are worried there may be low uptake MarketWatch
08:00AM	The 8 Most Profitable U.S. Companies Practically Print Money Investor's Business Daily
07:00AM	Moderna to Host R&D Day on Thursday, September 8, 2022 ACCESSWIRE
06:25AM	Swiss regulator grants temporary authorization for Moderna bivalent COVID booster for adults age 18 and older MarketWatch
06:10AM	Swissmedic Authorizes Modernas Omicron-Targeting Bivalent Booster Candidate, MRNA-1273.214 ACCESSWIRE
06:00AM	Better COVID Booster Stock: Moderna vs. Pfizer Motley Fool
Aug-28-22 06:00AM	Could This Move by Moderna Cost Pfizer Billions? Motley Fool
05:30AM	Latest Covid Boosters Are Set to Roll Out Before Human Testing Is Completed The Wall Street Journal
Aug-26-22 06:17PM	Nordstrom, Twitter Peloton: Stocks That Defined the Week The Wall Street Journal
04:42PM	Moderna Signals End Of Pandemic By Suing Pfizer, BioNTech Over Covid Shots Investor's Business Daily
04:31PM	Moderna Sues Pfizer and BioNTech, Alleging mRNA Patent Infringement The Wall Street Journal
03:54PM	Moderna Is Suing Pfizer and BioNTech for Covid-19 Vaccine Patent Infringement. What to Know. Barrons.com
03:22PM	The Covid Gambit: Pfizer, Moderna Struggle To Get The Jump On Covid Investor's Business Daily
01:41PM	Moderna sets up clash with Pfizer and BioNTech with patent lawsuits in the U.S. and Germany MarketWatch
01:20PM	Pfizer 'surprised' by Moderna COVID-19 vaccine patent lawsuit Yahoo Finance
12:09PM	Pfizer-BioNTech surprised by Moderna lawsuit alleging they copied COVID-19 vaccine technology Fortune
11:08AM	Pfizer prepared to vigorously defend itself against Modernas allegations Yahoo Finance Video
10:48AM	Moderna Sues Pfizer, BioNTech Over Covid Vaccine Technology Bloomberg
10:07AM	Report finds Americans with long COVID losing billions in wages, as Moderna sues Pfizer and BioNTech over mRNA patents MarketWatch
09:41AM	Moderna accuses Pfizer of copying patented technology behind Covid-19 vaccine in new lawsuit American City Business Journals
09:38AM	Moderna sues Pfizer, BioNTech over COVID vaccine patent Yahoo Finance Video
09:24AM	Moderna Entangles Pfizer/BioNTech In COVID-19 Vaccine Patent Lawsuits: All You Need To Know Benzinga
08:28AM	Moderna Sues Pfizer, BioNtech For Covid Vaccine Patent Infringement TheStreet.com
08:14AM	Moderna sues Pfizer and BioNTech for patent infringement relating to the mRNA platform used to develop COVID vaccines MarketWatch
08:04AM	Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine Reuters
08:00AM	Moderna accuses BioNTech/Pfizer of copying mRNA technology Financial Times
08:00AM	Moderna Sues Pfizer and BioNTech for Infringing Patents Central to Moderna's Innovative mRNA Technology Platform ACCESSWIRE
Aug-25-22 10:07AM	1 Bear Market Blunder Investors Are Still Making Motley Fool
06:30AM	EXPLAINER-Updated COVID-19 vaccines are coming in the U.S., should you get one? Reuters
06:27AM	The Petri Dish: Cancer startup heads to Texas, Moderna submits new booster data American City Business Journals
05:52AM	The Zacks Analyst Blog Highlights Pfizer, BioNTech, Moderna and Morphic Zacks
Aug-24-22 04:31PM	Africa: Why COVID vaccine inequity is still a big, and deadly, problem for all of us Yahoo Finance
02:35PM	The Fall Rollout of Covid-19 Boosters Looks Set to Start in Early September Barrons.com
12:40PM	Pfizer (PFE), BioNTech Post Data on COVID Jab for Kids Under 5 Zacks
12:27PM	Moderna (MRNA) Seeks FDA Nod for Omicron-Based COVID Jab Zacks
10:50AM	Moderna, Carnival, and Match Have a Lot to Do With S&P 500s Pullback From August Peak Barrons.com
10:06AM	Omicron-targeting COVID boosters may be out after Labor Day, and Moderna has joined Pfizer and BioNTech in filing for authorization MarketWatch
08:08AM	An FDA change to vaccine authorization allowed Pfizer and Moderna to apply for BA.5 booster approval without key data Fortune
06:11AM	Coronavirus tally: Omicron boosters may be ready after Labor Day as Moderna submits EUA application MarketWatch
Aug-23-22 08:46PM	Omicron-specific boosters could be rolled out after Labor Day: report MarketWatch
04:48PM	Moderna Asks FDA To Sign Off On Updated Covid Booster, Trailing Pfizer By A Day Investor's Business Daily
04:42PM	Moderna completes FDA submission for new COVID-19 booster MarketWatch
04:37PM	Moderna Asks FDA to OK Updated Covid-19 Shot The Wall Street Journal

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bancel Stephane	Chief Executive Officer	Sep 01	Option Exercise	0.99	40,000	39,600	5,451,946	Sep 02 04:04 PM
Bancel Stephane	Chief Executive Officer	Sep 01	Sale	133.59	40,000	5,343,745	5,411,946	Sep 02 04:04 PM
Bancel Stephane	Chief Executive Officer	Sep 01	Sale	131.13	10,000	1,311,300	6,734,880	Sep 02 04:04 PM
Bancel Stephane	Chief Executive Officer	Aug 31	Option Exercise	0.99	40,000	39,600	5,451,946	Sep 02 04:04 PM
AFEYAN NOUBAR	Director	Aug 31	Sale	136.95	10,000	1,369,500	2,437,209	Sep 02 07:30 PM
Bancel Stephane	Chief Executive Officer	Aug 31	Sale	133.84	40,000	5,353,444	5,411,946	Sep 02 04:04 PM
Hoge Stephen	President	Aug 29	Sale	135.81	1,119	151,974	1,625,800	Aug 30 04:04 PM
Andres Juan	See remarks	Aug 29	Sale	135.81	839	113,947	11,566	Aug 30 04:08 PM
Hoge Stephen	President	Aug 26	Option Exercise	0.00	2,410	0	1,626,919	Aug 30 04:04 PM
Andres Juan	See remarks	Aug 26	Option Exercise	0.00	1,807	0	12,405	Aug 30 04:08 PM
Bancel Stephane	Chief Executive Officer	Aug 25	Option Exercise	0.99	40,000	39,600	5,451,946	Aug 26 04:07 PM
Bancel Stephane	Chief Executive Officer	Aug 25	Sale	140.27	40,000	5,610,890	5,411,946	Aug 26 04:07 PM
Bancel Stephane	Chief Executive Officer	Aug 25	Sale	142.25	10,000	1,422,500	6,744,880	Aug 26 04:07 PM
Bancel Stephane	Chief Executive Officer	Aug 24	Option Exercise	0.99	40,000	39,600	5,451,946	Aug 26 04:07 PM
Hoge Stephen	President	Aug 24	Option Exercise	10.90	5,000	54,500	1,629,509	Aug 25 04:27 PM
Bancel Stephane	Chief Executive Officer	Aug 24	Sale	142.21	40,000	5,688,389	5,411,946	Aug 26 04:07 PM
Hoge Stephen	President	Aug 24	Sale	142.80	5,000	714,000	1,624,509	Aug 25 04:27 PM
Hoge Stephen	President	Aug 23	Option Exercise	10.90	5,000	54,500	1,629,509	Aug 25 04:27 PM
Hoge Stephen	President	Aug 23	Sale	141.70	5,000	708,500	1,624,509	Aug 25 04:27 PM
Bancel Stephane	Chief Executive Officer	Aug 18	Option Exercise	0.99	40,000	39,600	5,451,946	Aug 19 04:45 PM
Bancel Stephane	Chief Executive Officer	Aug 18	Sale	150.94	40,000	6,037,403	5,411,946	Aug 19 04:45 PM
Bancel Stephane	Chief Executive Officer	Aug 18	Sale	157.00	10,000	1,570,000	6,754,880	Aug 19 04:45 PM
Bancel Stephane	Chief Executive Officer	Aug 17	Option Exercise	0.99	40,000	39,600	5,451,946	Aug 19 04:45 PM
Andres Juan	See remarks	Aug 17	Option Exercise	20.93	2,000	41,860	12,598	Aug 19 04:56 PM
Bancel Stephane	Chief Executive Officer	Aug 17	Sale	159.03	40,000	6,361,170	5,411,946	Aug 19 04:45 PM
Andres Juan	See remarks	Aug 17	Sale	165.24	2,000	330,480	10,598	Aug 19 04:56 PM
AFEYAN NOUBAR	Director	Aug 17	Sale	165.24	10,000	1,652,400	2,447,209	Aug 19 07:30 PM
Hoge Stephen	President	Aug 15	Option Exercise	10.90	5,000	54,500	1,629,509	Aug 16 04:49 PM
Hoge Stephen	President	Aug 15	Sale	172.85	5,000	864,250	1,624,509	Aug 16 04:49 PM
Hoge Stephen	President	Aug 12	Option Exercise	10.90	5,000	54,500	1,629,509	Aug 16 04:49 PM
Hoge Stephen	President	Aug 12	Sale	172.68	5,000	863,400	1,624,509	Aug 16 04:49 PM
Bancel Stephane	Chief Executive Officer	Aug 11	Option Exercise	0.99	40,000	39,600	5,451,946	Aug 12 04:32 PM
Bancel Stephane	Chief Executive Officer	Aug 11	Sale	174.37	40,000	6,974,951	5,411,946	Aug 12 04:32 PM
Bancel Stephane	Chief Executive Officer	Aug 11	Sale	174.23	10,000	1,742,300	6,764,880	Aug 12 04:32 PM
Bancel Stephane	Chief Executive Officer	Aug 10	Option Exercise	0.99	40,000	39,600	5,451,946	Aug 12 04:32 PM
Andres Juan	See remarks	Aug 10	Option Exercise	20.93	2,000	41,860	12,598	Aug 11 04:57 PM
AFEYAN NOUBAR	Director	Aug 10	Sale	174.09	10,000	1,740,900	2,457,209	Aug 12 07:30 PM
Bancel Stephane	Chief Executive Officer	Aug 10	Sale	172.29	40,000	6,891,576	5,411,946	Aug 12 04:32 PM
Meline David W	Chief Financial Officer	Aug 10	Sale	173.66	164	28,481	2,857	Aug 11 04:52 PM
Andres Juan	See remarks	Aug 10	Sale	174.05	2,204	383,607	10,598	Aug 11 04:57 PM
Hoge Stephen	President	Aug 10	Sale	173.66	244	42,374	1,624,509	Aug 11 05:02 PM
Meline David W	Chief Financial Officer	Aug 09	Option Exercise	0.00	348	0	3,021	Aug 11 04:52 PM
Andres Juan	See remarks	Aug 09	Option Exercise	0.00	435	0	10,802	Aug 11 04:57 PM
Hoge Stephen	President	Aug 09	Option Exercise	0.00	522	0	1,624,753	Aug 11 05:02 PM
Bancel Stephane	Chief Executive Officer	Aug 04	Option Exercise	0.99	40,000	39,600	5,451,946	Aug 05 04:44 PM
Bancel Stephane	Chief Executive Officer	Aug 04	Sale	192.94	40,000	7,717,501	5,411,946	Aug 05 04:44 PM
Bancel Stephane	Chief Executive Officer	Aug 04	Sale	185.75	10,000	1,857,500	6,774,880	Aug 05 04:44 PM
Andres Juan	See remarks	Aug 03	Option Exercise	20.93	2,000	41,860	12,367	Aug 05 04:38 PM
Bancel Stephane	Chief Executive Officer	Aug 03	Option Exercise	0.99	40,000	39,600	5,451,946	Aug 05 04:44 PM
Andres Juan	See remarks	Aug 03	Sale	167.99	2,000	335,980	10,367	Aug 05 04:38 PM
Bancel Stephane	Chief Executive Officer	Aug 03	Sale	186.79	40,000	7,471,776	5,411,946	Aug 05 04:44 PM
AFEYAN NOUBAR	Director	Aug 03	Sale	167.99	10,000	1,679,900	2,467,209	Aug 05 07:30 PM
Bancel Stephane	Chief Executive Officer	Jul 28	Option Exercise	0.99	40,000	39,600	5,451,946	Jul 29 04:46 PM
Bancel Stephane	Chief Executive Officer	Jul 28	Sale	156.73	40,000	6,269,397	5,411,946	Jul 29 04:46 PM
Bancel Stephane	Chief Executive Officer	Jul 28	Sale	157.00	10,000	1,570,000	6,784,880	Jul 29 04:46 PM
Bancel Stephane	Chief Executive Officer	Jul 27	Option Exercise	0.99	40,000	39,600	5,451,946	Jul 29 04:46 PM
Andres Juan	See remarks	Jul 27	Option Exercise	20.93	2,000	41,860	12,367	Jul 29 04:47 PM
Bancel Stephane	Chief Executive Officer	Jul 27	Sale	156.32	40,000	6,252,642	5,411,946	Jul 29 04:46 PM
Andres Juan	See remarks	Jul 27	Sale	161.00	2,000	322,000	10,367	Jul 29 04:47 PM
AFEYAN NOUBAR	Director	Jul 27	Sale	161.00	10,000	1,610,000	2,477,209	Jul 29 07:30 PM
Hoge Stephen	President	Jul 25	Option Exercise	10.90	10,000	109,000	1,634,231	Jul 26 05:32 PM
Hoge Stephen	President	Jul 25	Sale	162.75	10,000	1,627,500	1,624,231	Jul 26 05:32 PM
Bancel Stephane	Chief Executive Officer	Jul 21	Option Exercise	0.99	40,000	39,600	5,451,946	Jul 22 04:42 PM
Bancel Stephane	Chief Executive Officer	Jul 21	Sale	168.11	40,000	6,724,218	5,411,946	Jul 22 04:42 PM
Bancel Stephane	Chief Executive Officer	Jul 21	Sale	165.36	10,000	1,653,600	6,794,880	Jul 22 04:42 PM
Bancel Stephane	Chief Executive Officer	Jul 20	Option Exercise	0.99	40,000	39,600	5,451,946	Jul 22 04:42 PM
Andres Juan	See remarks	Jul 20	Option Exercise	20.93	2,000	41,860	12,367	Jul 22 04:40 PM
Bancel Stephane	Chief Executive Officer	Jul 20	Sale	166.92	40,000	6,676,906	5,411,946	Jul 22 04:42 PM
Andres Juan	See remarks	Jul 20	Sale	167.00	2,000	334,000	10,367	Jul 22 04:40 PM
AFEYAN NOUBAR	Director	Jul 20	Sale	167.00	10,000	1,670,000	2,487,209	Jul 22 07:30 PM
Bancel Stephane	Chief Executive Officer	Jul 14	Option Exercise	0.99	40,000	39,600	5,451,946	Jul 15 04:34 PM
Bancel Stephane	Chief Executive Officer	Jul 14	Sale	160.56	40,000	6,422,590	5,411,946	Jul 15 04:34 PM
Bancel Stephane	Chief Executive Officer	Jul 14	Sale	169.31	10,000	1,693,100	6,804,880	Jul 15 04:34 PM
Hoge Stephen	President	Jul 13	Option Exercise	10.90	5,000	54,500	1,629,231	Jul 14 04:40 PM
Andres Juan	See remarks	Jul 13	Option Exercise	20.93	2,000	41,860	12,367	Jul 15 04:32 PM
Bancel Stephane	Chief Executive Officer	Jul 13	Option Exercise	0.99	40,000	39,600	5,451,946	Jul 15 04:34 PM
AFEYAN NOUBAR	Director	Jul 13	Sale	168.88	10,000	1,688,800	2,497,209	Jul 15 07:30 PM
Hoge Stephen	President	Jul 13	Sale	168.88	5,000	844,400	1,624,231	Jul 14 04:40 PM
Andres Juan	See remarks	Jul 13	Sale	168.88	2,000	337,760	10,367	Jul 15 04:32 PM
Bancel Stephane	Chief Executive Officer	Jul 13	Sale	172.69	40,000	6,907,792	5,411,946	Jul 15 04:34 PM
AFEYAN NOUBAR	Director	Jul 13	Sale	168.88	10,000	1,688,800	2,497,209	Jul 15 07:30 PM
Hoge Stephen	President	Jul 12	Option Exercise	10.90	5,000	54,500	1,629,231	Jul 14 04:40 PM
Hoge Stephen	President	Jul 12	Sale	174.73	5,000	873,650	1,624,231	Jul 14 04:40 PM
Bancel Stephane	Chief Executive Officer	Jul 07	Option Exercise	0.99	40,000	39,600	5,451,946	Jul 08 04:07 PM
Bancel Stephane	Chief Executive Officer	Jul 07	Sale	171.00	40,000	6,839,979	5,411,946	Jul 08 04:07 PM
Bancel Stephane	Chief Executive Officer	Jul 07	Sale	159.54	10,000	1,595,400	6,814,880	Jul 08 04:07 PM
Andres Juan	See remarks	Jul 06	Option Exercise	20.93	2,000	41,860	12,367	Jul 08 04:04 PM
Bancel Stephane	Chief Executive Officer	Jul 06	Option Exercise	0.99	40,000	39,600	5,451,946	Jul 08 04:07 PM
Andres Juan	See remarks	Jul 06	Sale	154.85	2,000	309,700	10,367	Jul 08 04:04 PM
Bancel Stephane	Chief Executive Officer	Jul 06	Sale	157.15	40,000	6,285,981	5,411,946	Jul 08 04:07 PM
AFEYAN NOUBAR	Director	Jul 06	Sale	154.85	10,000	1,548,500	2,507,209	Jul 08 07:30 PM
Andres Juan	See remarks	Jul 01	Option Exercise	20.93	6,000	125,580	16,367	Jul 05 04:59 PM
Andres Juan	See remarks	Jul 01	Sale	150.00	6,000	900,000	10,367	Jul 05 04:59 PM
Bancel Stephane	Chief Executive Officer	Jun 30	Option Exercise	0.99	40,000	39,600	5,451,946	Jul 01 04:16 PM
Bancel Stephane	Chief Executive Officer	Jun 30	Sale	143.21	40,000	5,728,547	5,411,946	Jul 01 04:16 PM
Bancel Stephane	Chief Executive Officer	Jun 30	Sale	143.40	10,000	1,434,000	6,824,880	Jul 01 04:16 PM
Bancel Stephane	Chief Executive Officer	Jun 29	Option Exercise	0.99	40,000	39,600	5,451,946	Jul 01 04:16 PM
AFEYAN NOUBAR	Director	Jun 29	Sale	140.47	10,000	1,404,700	2,517,209	Jul 01 07:30 PM
Bancel Stephane	Chief Executive Officer	Jun 29	Sale	142.47	40,000	5,698,798	5,411,946	Jul 01 04:16 PM
Hoge Stephen	President	Jun 24	Option Exercise	10.90	5,000	54,500	1,629,231	Jun 27 05:11 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience